University of Michigan Rogel Cancer Center: Drug Combination Reduces Breast Cancer Risk and Improves Metabolic Health in Rats
June 03, 2025
June 03, 2025
ANN ARBOR, Michigan, June 3 (TNSjou) -- The University of Michigan Rogel Cancer Center issued the following news release:
* * *
Drug combination reduces breast cancer risk and improves metabolic health in rats
Bazedoxifene and conjugated estrogens reversed obesity-associated changes, supporting their use in patients
Approximately 25% of women in the United States between ages 45 and 60 are at high risk for breast cancer and should consider prev . . .
* * *
Drug combination reduces breast cancer risk and improves metabolic health in rats
Bazedoxifene and conjugated estrogens reversed obesity-associated changes, supporting their use in patients
Approximately 25% of women in the United States between ages 45 and 60 are at high risk for breast cancer and should consider prev . . .